BCYC earnings at a glance
Bicycle Therapeutics plc (BCYC) is scheduled to report earnings on Thursday, October 29, 2026 — in 6 days. Analysts expect earnings per share of -$0.30, compared with -$0.85 in the same quarter last year (+65%). The options market is pricing a move of about ±22.4% after the report, a range of roughly $2.75 to $4.35 from today's $3.55. Over its last 6 reports the stock rose the next day 5 times and fell 1, moving ±3.4% on average; after the most recent report on Jul 30, 2026 it moved +3.9%. That means options currently expect more movement than BCYC has typically delivered. BCYC beat the consensus EPS estimate in 2 of its last 6 reported quarters. Implied volatility is currently 170%. The share price of $3.55 sits near its 52-week low.
Overview
Earnings trends
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu Jul 30, 2026 | 8K 2026-07-30 | $-0.72 | $-0.37 | -94.6% | — | +3.9% | earnings |
| Thu Apr 30, 2026 | 8K 2026-04-30 | $-0.87 | $-0.52 | -67.3% | — | -0.2% | earnings |
| Tue Mar 17, 2026 | 8K 2026-03-17 | $-0.29 | $-1.00 | +71.0% | — | +0.4% | earnings |
| Thu Oct 30, 2025 | Sep/2025 | $-0.85 | $-1.09 | +22.0% | — | +7.1% | earnings |
| Fri Aug 8, 2025 | Jun/2025 | $-1.14 | $-0.95 | -20.0% | — | +2.5% | earnings |
| Thu May 1, 2025 | Mar/2025 | $-0.88 | $-0.86 | -2.3% | — | +6.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.74 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.77 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.62 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.26 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.41 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.30 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Oct 29, 2026 | Sep/2026 | OTHER | -$0.30 | -$0.85 | +64.7% |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $629,000 | $887,000 | — | $12M | $3M | $10M | — | $3M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-55M | $-65M | — | $-66M | $-87M | $-70M | — | $-64M |
| Net income | $-50M | $-61M | — | $-59M | $-79M | $-61M | — | $-51M |
| EPS (diluted) | $-0.72 | $-0.87 | — | $-0.85 | $-1.14 | $-0.88 | — | $-0.74 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $510M | $559M | $628M | $648M | $721M | $793M | $880M | $891M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $575M | $619M | $683M | $739M | $804M | $856M | $929M | $966M |
| Total assets | $607M | $652M | $718M | $764M | $832M | $884M | $957M | $997M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $96M | $98M | $108M | $145M | $163M | $144M | $164M | $166M |
| Total equity | $510M | $554M | $610M | $618M | $669M | $740M | $793M | $831M |
Implied volatility — last 90 days
Sector peers
BCYC earnings FAQ
When is BCYC's next earnings date?
Bicycle Therapeutics plc is expected to report on October 29, 2026.
What is BCYC's expected move for earnings?
Options currently price a move of about ±22.4%, or $0.80 per share either way from $3.55.
How does BCYC stock usually react to earnings?
Across the last 6 reports the average next-day move was ±3.4%, up 5 times and down 1 times.
What EPS are analysts expecting from Bicycle Therapeutics plc?
The consensus estimate is -$0.30 per share, versus -$0.85 a year ago.
What is BCYC's implied volatility?
BCYC's at-the-money implied volatility is about 170% based on the latest options snapshot.